Suppr超能文献

I型唾液酸贮积症:眼科检查结果

Sialidosis type I: ophthalmological findings.

作者信息

Sobral Isa, Cachulo Maria da Luz, Figueira João, Silva Rufino

机构信息

Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.

出版信息

BMJ Case Rep. 2014 Oct 16;2014:bcr2014205871. doi: 10.1136/bcr-2014-205871.

Abstract

Sialidosis is a lysosomal storage disease caused by deficit of neuraminidase. It is an autosomal recessive disease, heterogeneous in its onset, presentation and prognosis. We report a case of a male patient with molecular and enzymatic confirmation of the diagnosis. Symptoms began at age 26 with reduced visual acuity, bilateral cherry-red spots and later myoclonus. A brother, now deceased, had the same confirmed disease. We describe the symptoms and clinical findings of the patient, as well review the current knowledge on the topic. With this report, we highlight the importance of a clinical history integrating all the patient's symptoms in order to achieve the diagnosis. In the presence of a cherry-red spot, a comprehensive study is mandatory. Despite being a rare disease, sialidosis carries a significant burden for its patients and its diagnosis should always be considered in the appropriate setting.

摘要

唾液酸沉积症是一种由神经氨酸酶缺乏引起的溶酶体贮积病。它是一种常染色体隐性疾病,在发病、表现和预后方面具有异质性。我们报告一例经分子和酶学确诊的男性患者病例。症状始于26岁,表现为视力下降、双侧樱桃红斑,随后出现肌阵挛。一名现已去世的兄弟也确诊患有相同疾病。我们描述了该患者的症状和临床发现,并回顾了关于该主题的当前知识。通过本报告,我们强调了整合患者所有症状的临床病史对于实现诊断的重要性。在出现樱桃红斑的情况下,必须进行全面检查。尽管唾液酸沉积症是一种罕见疾病,但它给患者带来了巨大负担,在适当情况下应始终考虑对其进行诊断。

相似文献

1
Sialidosis type I: ophthalmological findings.
BMJ Case Rep. 2014 Oct 16;2014:bcr2014205871. doi: 10.1136/bcr-2014-205871.
2
A sialidosis type I cohort and a quantitative approach to multimodal ophthalmic imaging of the macular cherry-red spot.
Br J Ophthalmol. 2021 Jun;105(6):838-843. doi: 10.1136/bjophthalmol-2020-316826. Epub 2020 Aug 4.
3
Sialidosis type I (cherry red spot-myoclonus syndrome).
J Indian Med Assoc. 2004 Mar;102(3):174-5.
5
Sialidosis: the cherry-red spot--myoclonus syndrome.
Can J Ophthalmol. 1980 Jan;15(1):35-9.
6
Clinical and electrophysiological characteristics of a type 1 sialidosis patient with a novel deletion mutation in NEU1 gene.
J Formos Med Assoc. 2020 Jan;119(1 Pt 3):406-412. doi: 10.1016/j.jfma.2019.07.017. Epub 2019 Jul 29.
7
Variable phenotype and severity of sialidosis expressed in two siblings presenting with ataxia and macular cherry-red spots.
J Clin Neurosci. 2013 Sep;20(9):1327-8. doi: 10.1016/j.jocn.2012.12.014. Epub 2013 Jul 16.
8
Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview.
Mol Genet Metab. 2020 Feb;129(2):47-58. doi: 10.1016/j.ymgme.2019.09.005. Epub 2019 Oct 31.
9
Optical coherence tomography findings in a patient with type 1 sialidosis.
J Clin Neurosci. 2016 Sep;31:199-201. doi: 10.1016/j.jocn.2016.02.015. Epub 2016 Apr 1.
10
A novel spot mutation leading to sialidosis type 1-myoclonus syndrome and optical coherence tomography findings.
Arq Bras Oftalmol. 2023 Apr 3;87(5):e20220069. doi: 10.5935/0004-2749.2022-0069. eCollection 2023.

引用本文的文献

1
Two cases of type I sialidosis and a literature review.
Orphanet J Rare Dis. 2024 Nov 27;19(1):440. doi: 10.1186/s13023-024-03431-3.
2
Progressive myoclonic ataxia as an initial symptom of typical type I sialidosis with NEU1 mutation.
Ann Clin Transl Neurol. 2024 Nov;11(11):2998-3009. doi: 10.1002/acn3.52212. Epub 2024 Oct 31.
3
Juvenile sialidosis: a rare case and review of the literature.
Ann Med Surg (Lond). 2024 Feb 28;86(4):2248-2252. doi: 10.1097/MS9.0000000000001768. eCollection 2024 Apr.
4
ILAE Genetics Literacy series: Progressive myoclonus epilepsies.
Epileptic Disord. 2023 Oct;25(5):670-680. doi: 10.1002/epd2.20152. Epub 2023 Sep 6.
5
NEU1-A Unique Therapeutic Target for Alzheimer's Disease.
Front Pharmacol. 2022 Jun 29;13:902259. doi: 10.3389/fphar.2022.902259. eCollection 2022.
6
Looking "Cherry Red Spot Myoclonus" in the Eyes: Clinical Phenotype, Treatment Response, and Eye Movements in Sialidosis Type 1.
Tremor Other Hyperkinet Mov (N Y). 2021 Dec 9;11:53. doi: 10.5334/tohm.652. eCollection 2021.
9
Bergmeister's papilla in a young patient with type 1 sialidosis: case report.
BMC Ophthalmol. 2020 Aug 31;20(1):356. doi: 10.1186/s12886-020-01628-1.
10
A sialidosis type I cohort and a quantitative approach to multimodal ophthalmic imaging of the macular cherry-red spot.
Br J Ophthalmol. 2021 Jun;105(6):838-843. doi: 10.1136/bjophthalmol-2020-316826. Epub 2020 Aug 4.

本文引用的文献

2
Lysosomal multienzyme complex: pros and cons of working together.
Cell Mol Life Sci. 2014 Jun;71(11):2017-32. doi: 10.1007/s00018-013-1538-3. Epub 2013 Dec 15.
3
Variable phenotype and severity of sialidosis expressed in two siblings presenting with ataxia and macular cherry-red spots.
J Clin Neurosci. 2013 Sep;20(9):1327-8. doi: 10.1016/j.jocn.2012.12.014. Epub 2013 Jul 16.
4
Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.
Biochim Biophys Acta. 2013 Oct;1832(10):1784-92. doi: 10.1016/j.bbadis.2013.06.002. Epub 2013 Jun 12.
5
Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene.
Intern Med. 2013;52(1):119-24. doi: 10.2169/internalmedicine.52.8901. Epub 2013 Jan 1.
6
The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis.
Mol Genet Metab. 2012 Sep;107(1-2):173-85. doi: 10.1016/j.ymgme.2012.07.013. Epub 2012 Jul 24.
7
Lysosomal multienzymatic complex-related diseases: a genetic study among Portuguese patients.
Clin Genet. 2012 Apr;81(4):379-93. doi: 10.1111/j.1399-0004.2011.01625.x. Epub 2011 Mar 1.
10
The "cherry red" spot.
Pediatr Neurol. 2007 Jul;37(1):74-5. doi: 10.1016/j.pediatrneurol.2007.04.011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验